These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 1906431)
1. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF. Beniers AJ; Peelen WP; Debruyne FM; Schalken JA Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431 [TBL] [Abstract][Full Text] [Related]
2. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma. Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818 [TBL] [Abstract][Full Text] [Related]
3. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells. Maio M; Gulwani B; Morgano A; Ferrone S Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138 [TBL] [Abstract][Full Text] [Related]
4. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines. Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249 [TBL] [Abstract][Full Text] [Related]
5. [Expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 (ICAM-1) on renal cell cancer. De novo expression and modulation by cytokines on renal cell cancer cell lines]. Tomita Y; Nishiyama T; Sato S; Fujiwara M Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):232-8. PubMed ID: 1674973 [TBL] [Abstract][Full Text] [Related]
6. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma. Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887 [TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes. Ogasawara M; Rosenberg SA Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762 [TBL] [Abstract][Full Text] [Related]
8. Induction of HLA class II antigens in osteosarcoma cells by interferons and tumor necrosis factor alpha. Scotlandi K; Baldini N; Campanacci M; Lollini PL; Picci P; Serra M Anticancer Res; 1992; 12(3):767-72. PubMed ID: 1622136 [TBL] [Abstract][Full Text] [Related]
9. Cytokine (IFN-alpha, IFN-gamma, IL-1-alpha, TNF-alpha)-induced modulation of HLA cell surface expression in human breast cancer cell lines. Sedlák J; Speiser P; Zeillinger R; Krugluger W; Wiltschke C; Kubista E; Chorváth B Neoplasma; 1992; 39(5):269-72. PubMed ID: 1436241 [TBL] [Abstract][Full Text] [Related]
10. Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell. Watanabe Y; Jacob CO J Immunol; 1991 Feb; 146(3):899-905. PubMed ID: 1899098 [TBL] [Abstract][Full Text] [Related]
11. cis-acting sequences required for class II gene regulation by interferon gamma and tumor necrosis factor alpha in a murine macrophage cell line. Freund YR; Dedrick RL; Jones PP J Exp Med; 1990 Apr; 171(4):1283-99. PubMed ID: 2109037 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts. van Dijk J; Uemura H; Beniers AJ; Peelen WP; Zegveld ST; Fleuren GJ; Warnaar SO; Oosterwijk E Int J Cancer; 1994 Jan; 56(2):262-8. PubMed ID: 8314310 [TBL] [Abstract][Full Text] [Related]
13. Interferon-beta and -gamma, but not tumor necrosis factor-alpha, demonstrate immunoregulatory effects on carcinoma cell lines infected with human papillomavirus. Bornstein J; Lahat N; Kinarty A; Revel M; Abramovici H; Shapiro S Cancer; 1997 Mar; 79(5):924-34. PubMed ID: 9041155 [TBL] [Abstract][Full Text] [Related]
14. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro. Akbasak A; Oldfield EH; Saris SC J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122 [TBL] [Abstract][Full Text] [Related]
15. Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-gamma and tumor necrosis factor-alpha. Vidovic M; Sparacio SM; Elovitz M; Benveniste EN J Neuroimmunol; 1990 Dec; 30(2-3):189-200. PubMed ID: 2121799 [TBL] [Abstract][Full Text] [Related]
16. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta. Shaw AR; Chan JK; Reid S; Seehafer J J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246 [TBL] [Abstract][Full Text] [Related]
17. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines. Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515 [TBL] [Abstract][Full Text] [Related]
18. Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas. Hoon DS; Okun E; Banez M; Irie RF; Morton DL Cancer Res; 1991 Oct; 51(20):5687-93. PubMed ID: 1913686 [TBL] [Abstract][Full Text] [Related]
19. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686 [TBL] [Abstract][Full Text] [Related]
20. Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells. Leeuwenberg JF; Van Damme J; Meager T; Jeunhomme TM; Buurman WA Eur J Immunol; 1988 Sep; 18(9):1469-72. PubMed ID: 3139431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]